May 2026

Tolu Minerals has revealed two new high-grade gold vein discoveries at its Tolukuma Gold Mine in Papua New Guinea, underpinning an ambitious near-mine drilling campaign aimed at boosting resource growth.

Galan Lithium has finished commissioning at its Hombre Muerto West project in Argentina, processing its first lithium chloride and aiming for product sales in the second half of 2026. The company is also preparing to expand production capacity by 30% in early 2027.

Atomic Eagle has sharpened its uranium exploration focus at Muntanga North, Zambia, completing 53 of 80 planned line kilometres of ground radiometric surveys that confirm and refine large-scale anomalies. Drilling is set to begin imminently on these high-priority targets.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.

Accelerate Resources has raised A$2 million in a two-tranche placement to fund aggressive exploration at its Balagundi Gold and Woodie Woodie North Manganese projects, aiming for a busy news flow through 2026.

Actinogen Medical has obtained positive scientific advice from the European Medicines Agency that aligns with prior FDA guidance, clarifying regulatory requirements for its Alzheimer’s drug Xanamem and paving the way for a streamlined approval process in major markets.

Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.

Viking Mines reports a major metallurgical breakthrough at its Linka Tungsten Project, achieving a 62.5% WO3 concentrate at 59.8% recovery using combined gravity and flotation processing on a larger 10 kg sample, significantly improving previous results and validating a low-capex flowsheet ahead of maiden drilling.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

BPH Global Ltd (ASX: BP8) posted its second best monthly seaweed trading result with gross sales of approximately A$391,000 in the twelfth month, pushing aggregate sales beyond A$3.3 million as Indonesian operations scale up post-monsoon.

The Therapeutic Goods Administration has broadened the range of clinicians eligible to participate in psychedelic-assisted psychotherapy, a move set to speed up recruitment and improve patient access across Emyria’s national Empax network.

Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.

Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Aspermont Limited (ASX:ASP) reported a 147% jump in net profit and 11% revenue growth for H1 FY26, driven by steady subscription growth and a ramp-up in non-subscription revenues. The company’s self-funded data and intelligence platform is on track, with Rio Tinto’s enterprise contract validating its strategic pivot.

Develop Global’s Pioneer Dome lithium project hits high-grade infill drilling results surpassing resource expectations, setting the stage for a Final Investment Decision next month on an 850,000-tonne DSO operation.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

ClearVue Technologies has won a significant contract to supply bespoke solar-integrated building materials for Canva’s new Sydney headquarters, marking a key commercial milestone.

Brightstar Resources has intersected visible gold in multiple deep diamond drillholes at Two Mile Hill, part of its Sandstone Gold Project. The drilling extends beyond 550m depth, underpinning plans for an underground mining study in the pre-feasibility study due later this year.

EV Resources has cleared a critical regulatory hurdle by obtaining the Change of Use of Soil permit for its Tecomatlán Plant, enabling the final environmental report filing and grid connection application that pave the way for near-term antimony production.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Western Ridge Resources has quintupled its Keystone Project footprint in Nevada, adding nearly 5,000 acres of prospective ground with historic mining activity but no modern exploration.

Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.

Sunshine Metals has secured $7.7 million through an oversubscribed Share Purchase Plan, exceeding its $3 million target, to fund the Mt Moss processing facility acquisition and Liontown mine start-up.